Clinical outcomes of intensive vs. less intensive first-line chemotherapy for metastatic colorectal cancer - supplementary material
收藏DataCite Commons2024-05-16 更新2025-04-15 收录
下载链接：
https://tandf.figshare.com/articles/dataset/Clinical_outcomes_of_intensive_vs_less_intensive_first-line_chemotherapy_for_metastatic_colorectal_cancer_-_supplementary_material/23607909
下载链接
链接失效反馈官方服务：
资源简介：
<strong>Supplementary Materials</strong>
<strong>Figure S1. Subgroup analysis of (A) TFST and (B) OS between the IT and LIT groups.</strong> TFST, time to first subsequent therapy; OS, overall survival; IT, intensive therapy; LIT, less-intensive therapy; CI, confidence interval; HR, hazard ratio.
<strong>Figure S2. Subgroup analysis of (A) TFST and (B) OS between the with- and without-MTA groups.</strong> TFST, time to first subsequent therapy; OS, overall survival; w/o, without; w/, with; MTA, molecularly targeted agent; CI, confidence interval; HR, hazard ratio.
<strong>Figure S3. Subgroup analysis of (A) TFST and (B) OS between the with- and without-BEV groups. </strong>TFST, time to first subsequent therapy; OS, overall survival; w/o, without; w/, with; BEV, bevacizumab; CI, confidence interval; HR, hazard ratio.
<strong>Table Supplemental 1.</strong> Patient characteristics and Barthel index scores
<strong>Table Supplemental 2.</strong> Patient characteristics in the with- and without-molecularly targeted agent (MTA) subgroups.
<strong>Table Supplemental 3.</strong> Patient characteristics in the intensive therapy (IT) and less-intensive therapy (LIT) subgroups.
提供机构：
Taylor & Francis
创建时间：
2023-06-30
